Anavex Life Sciences Corp (AVXL)

[JWC3]

You’re sane, and are making a very cogent argument about getting the word out concerning A 2-73. It helps folks with dimentia and has proven itself over the last 5 years. Only a few folks on this board care about Dimentia patients, so we must find the proper forum. Perhaps the government might care? They don’t know about A 2-73 and they are trying to get these Alzheimer patients to take BIIBs aducanumab, of all things. It failed its Phase 3 trial but the FDA still wants to give it to Alzheimer’s patients. How can we get the FDA to consider A 2-73? Maybe they will look at our P3 AD trial before it completes? A good number over 250 have completed the trial already. It is probably not necessary to stop and unblind in order for an oversight committee to evaluate efficacy estimates. We need to get FDA to provisionally approve A 2-73. Let’s give these Dimentia patients some hope.